Gemcitabine and CHK1 Inhibition Potentiate EGFR-Directed Radioimmunotherapy against Pancreatic Ductal Adenocarcinoma

Overview of attention for article published in Clinical Cancer Research, June 2014

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
Above-average Attention Score compared to outputs of the same age and source (54th percentile)

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 10,025 followers.

Gemcitabine and Chk1 Inhibition Potentiate EGFR-Directed Radioimmunotherapy against Pancreatic Ductal Adenocarcinoma http://t.co/3oNmz80Kav

Gemcitabine and Chk1 inhibition potentiate EGFR-directed radioimmunotherapy against pancreati http://t.co/bISRyPKAz2 http://t.co/1kv8RaZBGe

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.